| MDVYX | VIVAX | MDVYX / VIVAX | |
| Total Expense Ratio | 0.84 | 0.17 | 494% |
| Annual Report Gross Expense Ratio | 0.84 | 0.17 | 494% |
| Fund Existence | 21 years | 33 years | - |
| Gain YTD | -13.481 | 9.329 | -145% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 445M | 208B | 0% |
| Annual Yield % from dividends | 1.73 | 1.98 | 88% |
| Returns for 1 year | -23.43 | 5.05 | -464% |
| Returns for 3 years | -30.68 | 30.23 | -102% |
| Returns for 5 years | -16.36 | 62.93 | -26% |
| Returns for 10 years | -32.41 | 123.10 | -26% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LFSC | 34.39 | 0.33 | +0.96% |
| F/m Emerald Life Sciences Innovation ETF | |||
| DUBS | 36.64 | 0.16 | +0.43% |
| Aptus Large Cap Enhanced Yield ETF | |||
| RSEE | 32.66 | 0.04 | +0.11% |
| Rareview Systematic Equity ETF | |||
| BSCW | 20.83 | -0.01 | -0.05% |
| Invesco BulletShares 2032 Corp Bd ETF | |||
| IMST | 17.87 | -1.86 | -9.41% |
| Bitwise MSTR Option Income Strategy ETF | |||